Pyriproxyfen


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:31807242IVR1200 mg/kg/day 1200 mg/kg/dayAlterations in number of leydig cellsReproductive endocrine-mediated perturbations
IVR1200 mg/kg/day 1200 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR1200 mg/kg/day 1200 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR1200 mg/kg/day 1200 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR1200 mg/kg/day 1200 mg/kg/dayChanges in testicular morphologyReproductive endocrine-mediated perturbations
IVR40 mg/kg/day -No significant effects observed-
IVR20 mg/kg/day -No significant effects observed-
IVR100 mg/kg/day 100 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR200 mg/kg/day 200 mg/kg/dayChanges in testicular morphologyReproductive endocrine-mediated perturbations
IVR320 mg/kg/day 320 mg/kg/dayAlterations in number of leydig cellsReproductive endocrine-mediated perturbations
IVR320 mg/kg/day 320 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations
IVR320 mg/kg/day 320 mg/kg/dayChanges in testicular morphologyReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayDecreased testis weightsReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayAlterations in number of leydig cellsReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayChanges in morphology of seminiferous tubulesReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayChanges in testicular morphologyReproductive endocrine-mediated perturbations
IVR600 mg/kg/day 600 mg/kg/dayReduced sperm countsReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.